跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,108 条关于
“Fujian Shengdi Pharmaceutical”
全部
15,108
临床试验
1,856
药物
2,051
机构
2,211
资讯
8,990
12天前
China NMPA Accepts Marketing Authorization Application for Hengrui's Ripretinib Injection
去年
Guangshengtang's Innovative Hepatitis B Drug Included in Breakthrough Therapy List
去年
VR-Assisted Training Shows Promise in Alleviating Depression in Parkinson's Disease Patients
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Chinese Pharmaceutical Companies Pivot from Weight-Loss Drug Compounding to Generic Development as FDA Restrictions Tighten
3天前
EU Officials Tout Pending Pharmaceutical Reforms
去年
Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024
去年
Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration
去年
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
SPIMA Therapeutics Launches with Focus on Peptide-Based Immunotherapies for Unmet Needs
第 1 页，共 899 页
上一页
下一页
